HOAN NGUYEN: Open Payments
NPI 1588378699 · REDWOOD CITY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,979 in 124 payments from 17 companies in 2025. Trend: 2023 $1,339 · 2024 $2,347 · 2025 $2,979
Food & beverage: $2,979
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 24 | $806 |
| ABBVIE INC. | 35 | $650 |
| Celltrion USA Inc. | 13 | $281 |
| Janssen Biotech, Inc. | 12 | $196 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 15 | $192 |
| Lilly USA, LLC | 5 | $141 |
| Myriad Genetic Laboratories, Inc. | 1 | $126 |
| ViiV Healthcare Company | 1 | $122 |
| Phathom Pharmaceuticals, Inc. | 3 | $81 |
| PFIZER INC. | 3 | $76 |
Products named: REZDIFFRA, RINVOQ, VEGZELMA, TREMFYA, XIFAXAN, OMVOH, PRECISETUMOR, APRETUDE.
Industry payments across CA — which companies pay providers there.
